Vaylen Tirzepatide Review: A Confirmed 404 & Honest Verdict (2026)

This review's most important finding, confirmed directly: Vaylen's website, joinvaylen.com, currently returns a 404 "Page not found" error rather than a working site — the provider's own page states the URL "doesn't exist or has been moved." Every fact here comes from the company's own published program plus this review's own direct verification.

A confirmed 404 on Vaylen's own site

This review independently checked Vaylen's website directly at joinvaylen.com and confirmed it currently returns a genuine 404 error page — "The page you are looking for doesn't exist or has been moved." This isn't a temporary loading issue; it's the site's own error page rendering correctly, just for a nonexistent route. This could mean the provider has shut down, rebranded, or migrated to a new domain — this review couldn't determine which as of this check.

What Vaylen was

Vaylen positioned itself as a pure GLP-1 specialist — not a multi-category telehealth platform — offering both compounded semaglutide and tirzepatide plus brand-name Ozempic, Zepbound, and Wegovy, with an oral GLP-1 option and all-50-state coverage.

What Vaylen cost

Compounded semaglutide ran $179/month, compounded tirzepatide $239/month, and brand-name options near retail pricing ($997-$1,086/month). Given the confirmed 404, none of this pricing can currently be verified as active.

The brand-vs-compounded question

Vaylen offered both compounded and brand-name tirzepatide. Compounded tirzepatide is pharmacy-made, not itself an FDA-approved finished drug, and was not the specific product studied in the pivotal trials. See our guide to whether compounded tirzepatide is still legal in 2026 for the regulatory picture.

How the care model holds up

Given the confirmed 404 on Vaylen's own website, this review cannot verify that this provider is currently operating or accepting new patients. As with any provider whose website returns an error, do not attempt to sign up or provide payment information — verify the company's current status independently before considering it; tirzepatide carries labeled warnings for acute pancreatitis, gallbladder disease, and a boxed thyroid C-cell tumor warning — see our guides on Zepbound side effects, the gallbladder risk, and the thyroid cancer warning.

Does the drug work? (Separate from the provider)

Judge the provider on price, oversight and disclosure; judge the molecule on its trials. Tirzepatide's are strong — roughly 15–21% of body weight over 72 weeks in SURMOUNT-1¹, and better than semaglutide head-to-head² — but they were run on the brand drug at FDA-approved doses. Our tirzepatide evidence guide has the full picture.

The honest verdict

This review confirmed directly that Vaylen's website currently returns a 404 error — treat this listing as inactive until proven otherwise, and don't attempt to sign up. For a genuinely active pure GLP-1 specialist, compare it against Tyde Wellness or CoreAge Rx. For another listing whose headline price this review found doesn't hold up under scrutiny, see WeightRx. For a listing with a far more serious confirmed finding — an active FDA warning letter — see Zealthy. See our best tirzepatide providers ranking for the full field.